Cyclam-based antibacterial molecules eradicate Gram-negative superbugs with potent efficacy against human corneal infection.

Konai, Mohini Mohan; Pakrudheen, Iqbal; Barman, Swagatam; Sharma, Natalia; Tabbasum, Khatija; Garg, Prashant; Haldar, Jayanta

Konai, Mohini Mohan; Pakrudheen, Iqbal; Barman, Swagatam; Sharma, Natalia; Tabbasum, Khatija; Garg, Prashant; Haldar, Jayanta.

Affiliation

Konai MM; Antimicrobial Research Laboratory, New Chemistry Unit and School of Advanced Materials, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India. jayanta@jncasr.ac.in.

Chem Commun (Camb) ; 56(14): 2147-2150, 2020 Feb 18.

Article in En | MEDLINE | ID: mdl-31970367

Subject(s)

Anti-Bacterial Agents/pharmacology; Corneal Diseases/drug therapy; Gram-Negative Bacteria/drug effects; Heterocyclic Compounds/pharmacology; Anti-Bacterial Agents/chemistry; Drug Resistance, Multiple, Bacterial/drug effects; Heterocyclic Compounds/chemistry; Humans; Microbial Sensitivity Tests

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Corneal Diseases / Gram-Negative Bacteria / Heterocyclic Compounds / Anti-Bacterial Agents Limits: Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2020 Document type: Article Affiliation country: India Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google